🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tony Zhuang

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-1729-4629

Also affiliated with Emory University, Outcomes Research Consortium

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors”.

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2022)10.1093/oncolo/oyac236

N/A

0DataRank · unranked

13 citations

Deepak Ravindranathan, Yuan Liu, Dylan J. Martini, Jacqueline T. Brown, Bassel Nazha +8 more

478 Real-world outcomes in patients with penile squamous cell carcinoma (pSCC) receiving immune checkpoint inhibitors (ICI)

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0478

N/A

0DataRank · unranked

3 citations

Subir Goyal, Jacqueline Brown, Bradley Curtis Carthon, Ömer Küçük, Greta R. McClintock +5 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0DataRank · unranked

56 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.05.001

N/A

0DataRank · unranked

7 citations

Ashley A. McCook‐Veal, Jeffrey M. Switchenko, Tim Niyogusaba, Erica S. Tarabadkar, Katelin Baird +5 more

Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.11

N/A

0DataRank · unranked

2 citations

Subir Goyal, Jacqueline T. Brown, Bradley Curtis Carthon, Ömer Küçük, Greta Russler McClintock +5 more

Characterizing outcomes in severe cytopenias by 3 months in BCMA and CD19 CAR-T cell therapies: A single institution experience.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e19504

N/A

0DataRank · unranked

1 citations

Manali Rupji, Pranav R. Santapuram, Michael Graiser, Jason T. Romancik, Jonathon B. Cohen +1 more

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-19

N/A

0DataRank · unranked

4 citations

Subir Goyal, Katherine Case, T. Anders Olsen, Shalini Vemuru, Ahmet Yıldırım +8 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800

N/A

0DataRank · unranked

4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

Quantitative computed tomography analysis of body composition changes in paediatric patients with acute lymphoblastic leukaemia

British Journal of Haematology(2024)10.1111/bjh.19310

N/A

0DataRank · unranked

2 citations

Adrian A. Ong, Rikeenkumar Dhaduk, Deqing Pei, Mayuko Iijima, Eric Merkle +12 more

SOHO State of the Art Updates and Next Questions | Novel Immunotherapy Combinations for the Treatment of Indolent B-Cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.01.021

N/A

0DataRank · unranked

3 citations

Chen Zhang, Paolo Strati, Tony Zhuang

271 | LEUKEMIC NON‐NODAL MANTLE CELL LYMPHOMA IS NOT NECESSARILY EQUIVALENT TO INDOLENT MCL: A REPORT FROM THE LEO COHORT STUDY

Hematological Oncology(2025)10.1002/hon.70094_271

N/A

0DataRank · unranked

0 citations

Yihua Chen, Jeffrey M. Switchenko, Suheil Albert Atallah‐Yunes, Georgio Pongas, Mary P. Watkins +16 more